ETHESDA, Md.--(BUSINESS WIRE)--Global Medical REIT Inc. (NYSE:GMRE) (the “Company”), today announced that on July 20, 2017 it closed on the issuance of an additional 525,000 shares of its common stock at the public offering price of $9.00 per share, for total gross proceeds of approximately $4.7 million. This issuance was pursuant to the exercise of the underwriters’ over-allotment option following the Company’s previously announced public offering of 3.5 million shares of its common stock at a public offering price of $9.00 per share that closed on June 30, 2017. After giving effect to the initial offering and the full exercise of this over-allotment option, the total number of shares of common stock sold by the Company in the public offering was 4,025,000 shares and gross proceeds were approximately $36.2 million.

Janney Montgomery Scott, Wunderlich and BMO Capital Markets served as joint book-running managers for the offering. BB&T Capital Markets, D.A. Davidson & Co. and Oppenheimer & Co. served as co-managers for the offering.

About Global Medical REIT Inc.

Global Medical REIT Inc. is a Maryland corporation engaged primarily in the acquisition of licensed, state-of-the-art, purpose-built healthcare facilities and the leasing of these facilities to strong clinical operators with leading market share. The Company intends to produce increasing, reliable rental revenue by expanding its portfolio, and leasing each of its healthcare facilities to market-leading operators under a long-term triple-net lease. The Company’s management team has significant healthcare, real estate and public real estate investment trust, or REIT, experience and has long-established relationships with a wide range of healthcare providers. The Company intends to elect to be taxed as a REIT for U.S. federal income tax purposes, commencing with its taxable year ended December 31, 2016.